BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/14/2021 11:08:14 AM | Browse: 378 | Download: 748
 |
Received |
|
2021-02-18 10:50 |
|
Peer-Review Started |
|
2021-02-19 03:25 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-03-29 21:18 |
|
Revised |
|
2021-04-12 02:03 |
|
Second Decision |
|
2021-06-23 12:46 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2021-06-23 13:08 |
|
Articles in Press |
|
2021-06-23 13:08 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-07-06 09:06 |
|
Typeset the Manuscript |
|
2021-08-05 08:56 |
|
Publish the Manuscript Online |
|
2021-08-14 11:08 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Minireviews |
| Article Title |
Recent update on comprehensive therapy for advanced hepatocellular carcinoma
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Hui Wang and Wei Li |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Nature Science Foundation of The Science and Technology Bureau of Jilin Province |
20190201227JC |
| Innovation capacity-building fund of The Development and Reform Commission of Jilin Province |
2019C015 |
|
| Corresponding Author |
Wei Li, MD, PhD, Professor, Department of Hepatobiliary-Pancreatic Surgery, China-Japan Union Hospital of Jilin University, No. 126 Xiantai Street, Changchun 130033, Jilin Province, China. weili888@jlu.edu.cn |
| Key Words |
Hepatocellular carcinoma; Local treatment; Targeted therapy; Immunotherapy; Comprehensive therapy; Multidisciplinary therapy |
| Core Tip |
Hepatocellular carcinoma (HCC) is one of the most common malignant tumors in the world. The curative effect can be achieved only for early stage HCC, and it is easy to recurrence and metastasis after surgery, the 5-years recurrence rate is as high as 70%. Recently, the systematic treatment of advanced HCC has made a breakthrough. Multidisciplinary comprehensive treatment mode including targeted and immunotherapy has become an effective strategy and inevitable trend for the treatment of advanced HCC. Combined therapy has greatly improved the prognosis of HCC patients and opened up a new milestone. |
| Publish Date |
2021-08-14 11:08 |
| Citation |
Wang H, Li W. Recent update on comprehensive therapy for advanced hepatocellular carcinoma. World J Gastrointest Oncol 2021; 13(8): 845-855 |
| URL |
https://www.wjgnet.com/1948-5204/full/v13/i8/845.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v13.i8.845 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
